Related Experiment Video
Updated: Feb 28, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Restricted Ventilation Associated with Reduced Neurodevelopmental Impairment in Preterm Infants
Roseanne J S Vliegenthart1, Wes Onland, Aleid G van Wassenaer-Leemhuis
1Department of Neonatology, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.
Insights
Restricting invasive mechanical ventilation for preterm infants is feasible and may reduce the combined risk of death or neurodevelopmental impairment. This approach shows promise for improving outcomes in extremely premature babies.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Respiratory Physiology
Background:
- Bronchopulmonary dysplasia (BPD) is a risk associated with invasive mechanical ventilation (IMV) in preterm infants.
- Optimizing respiratory support strategies is crucial for improving outcomes in extremely premature neonates.
- Neurodevelopmental impairment (NDI) is a significant concern in survivors of preterm birth.
Purpose of the Study:
- To evaluate the impact of a restrictive invasive mechanical ventilation (IMV) policy on neurodevelopmental impairment (NDI) at 24 months corrected age (CA).
- To assess the feasibility and outcomes associated with reduced IMV use in preterm infants.
- To compare the incidence of BPD and NDI between two epochs with different ventilation strategies.
Main Methods:
- Retrospective cohort study of preterm infants (gestational age <30 weeks) born in two distinct periods (2004/2005 vs. 2010/2011).
- Epoch 2 implemented a policy of restricted IMV and increased use of noninvasive respiratory support and stimulants.
- Data collected included patient characteristics, respiratory management, BPD, mortality, and NDI at 24 months' CA.
Main Results:
- Infants in the restricted IMV epoch (epoch 2) had significantly less intubation and shorter IMV duration.
- Use of noninvasive therapies like caffeine, doxapram, and nasal ventilation increased in epoch 2.
- The combined outcome of death or NDI at 24 months' CA was significantly lower in epoch 2 (24.7%) compared to epoch 1 (33.9%).
Conclusions:
- A restrictive approach to IMV in preterm infants is achievable.
- Restricted IMV may be associated with a reduced risk of combined death or NDI at 24 months' CA.
- Further research is warranted to validate these findings in larger cohorts.
Background And Objective:
Restrictive use of invasive mechanical ventilation (IMV) in preterm infants reduces the risk of bronchopulmonary dysplasia (BPD). Our objective was to determine its effect on neurodevelopmental impairment (NDI) at 24 months' corrected age (CA).
Methods:
This retrospective single-center cohort study included all patients with a gestational age <30 weeks born in 2004/2005 (epoch 1) and 2010/2011 (epoch 2). In epoch 2, we introduced a policy of restriction on IMV and liberalized the use of respiratory stimulants in the delivery room and neonatal intensive care. Data on patient characteristics, respiratory management, short-term outcomes, mortality, BPD, and NDI at 24 months' CA were collected.
Results:
Four hundred and four preterm infants were included. Compared to those in epoch 1, infants in epoch 2 were less likely to be intubated and the duration of IMV was shorter. Other noninvasive adjuvant therapies such as caffeine, doxapram, and nasal ventilation were more often used during epoch 2. There was a trend to less BPD in epoch 2 compared to epoch 1 (17 vs. 23%, adjusted OR = 0.75, 95% CI: 0.48, 1.16). Mortality did not change over time. The combined outcome death or NDI at 24 months' CA was significantly lower in epoch 2 compared to epoch 1 (24.7 vs. 33.9%, adjusted OR = 0.71, 95% CI: 0.53, 0.97).
Conclusions:
Restricted use of IMV is feasible in preterm infants and might be associated with a reduced risk of the combined outcome death or NDI at 24 months' CA. Larger studies are needed to confirm these findings.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Cycle: Exhalation
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:

